{
    "organizations": [],
    "uuid": "4d60a2d89742287f101281ab60f5df7dd4f9d84a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-biocancell-announces-23-million-pi/brief-biocancell-announces-23-million-pipe-financing-idUSASC09VT1",
    "ord_in_thread": 0,
    "title": "BRIEF-Biocancell Announces $23 Million Pipe Financing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 13, 2018 / 12:26 PM / Updated 11 minutes ago BRIEF-Biocancell Announces $23 Million Pipe Financing Reuters Staff \nApril 13 (Reuters) - Biocancell Ltd: * BIOCANCELL ANNOUNCES $23 MILLION PIPE FINANCING \n* HAS EXECUTED BINDING FUNDING AGREEMENTS TO RAISE $22.8 MILLION THROUGH A PRIVATE EQUITY INVESTMENT \n* PROCEEDS WILL BE USED PRIMARILY TO ADVANCE COMPANYâ€™S DRUG DEVELOPMENT PROGRAMS Source text for Eikon: Further company coverage:",
    "published": "2018-04-13T15:23:00.000+03:00",
    "crawled": "2018-04-13T15:39:00.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "million",
        "pipe",
        "financing",
        "reuters",
        "staff",
        "april",
        "reuters",
        "biocancell",
        "ltd",
        "biocancell",
        "announces",
        "million",
        "pipe",
        "financing",
        "executed",
        "binding",
        "funding",
        "agreement",
        "raise",
        "million",
        "private",
        "equity",
        "investment",
        "proceeds",
        "used",
        "primarily",
        "advance",
        "company",
        "drug",
        "development",
        "program",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}